Bright Minds Biosciences has debuted glowing phase 2 results for its lead anti-seizure asset, giving the biotech’s stock a ...
BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% ...
Epilepsy is not a one size fits all condition and there are a few tell tale signs that parents could miss, said Dr Jonathan ...
Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...
They can hurt more than broken bones or pancreatitis. But with the right drugs and therapies, relief is possible from this debilitating and often misunderstood condition ...
Migraines affect millions in the UK, yet are often misunderstood and underestimated. From throbbing pain and nausea to ...
Pulsetto Bilateral Cervical Neuromodulation Device Evaluation: Session Duration, General Wellness Positioning, User-Reported ...
Trump suggest the U.S. oil industry could benefit from investing in rebuiling Venezuela's infrastructure. The CDC overhauls ...
Twenty-five years after I revealed the practices of the industrial food giants, the profits – and dangers – of mass producing meat and milk have only grown ...
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...
Experts and activists have warned that complacency may cause a resurgence of the epidemic that has claimed more than 40 million people. A number of young people do not think HIV is not a problem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback